Interfant 99.

International collaborative treatment protocol for infants under one year with acute lymphoblastic leukemia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21662

Enrollment

500

Registered

2005-09-05

Start date

1999-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia.

Interventions

Intensification course VIMARAM.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age < 366 days; 2. Acute lymphoblastic leukemia.

Exclusion criteria

Exclusion criteria: Prior therapy for leukemia (except emergency treatment).

Design outcomes

Primary

Measure	Time frame
Event Free Survival.	—

Contacts

Public ContactRob Pieters

Erasmus Medical Center, Sophia Children's Hospital, Department of Oncology/Hematology, P.O. Box 2060

rob.pieters@erasmusmc.nl+31 (0)10 4636691

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)